{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:20:30Z","timestamp":1791350430441,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cca.2025.120447","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T18:51:25Z","timestamp":1750704685000},"page":"120447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay"],"prefix":"10.1016","volume":"577","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-494X","authenticated-orcid":false,"given":"Ronald A.","family":"Booth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Beriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Benkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline A.J.","family":"Willemse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra Maleska","family":"Maceski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120447_b0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0010","article-title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","volume":"59","author":"Thebault","year":"2022","journal-title":"Mult. Scler. Relat. Dis."},{"key":"10.1016\/j.cca.2025.120447_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104662","article-title":"Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials","volume":"93","author":"Bar-Or","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.cca.2025.120447_b0020","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00415-023-12135-w","article-title":"Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing\u2013remitting multiple sclerosis: a 20-year follow-up cohort","volume":"271","author":"Pereiro","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0025","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120447_b0030","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1212\/NXI.0000000000000422","article-title":"Neurofilament light chain predicts disease activity in relapsing-remitting MS","volume":"5","author":"Varhaug","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.cca.2025.120447_b0035","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1177\/13524585231198751","article-title":"Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis","volume":"29","author":"Bose","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.cca.2025.120447_b0040","article-title":"Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: a post hoc analysis of the randomized CombiRx trial","volume":"9","author":"Cutter","year":"2023","journal-title":"Mult. Scler. J. Exp., Transl. Clin."},{"key":"10.1016\/j.cca.2025.120447_b0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2023.0010","article-title":"Association of serum neurofilament light chain levels at disease onset with disability worsening in patients with a first demyelinating multiple sclerosis event not treated with high-efficacy drugs","volume":"80","author":"Monreal","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"N.R.D. in the S.M.S.C.S. Group, Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.cca.2025.120447_b0055","article-title":"Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis","volume":"6","author":"Srpova","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.cca.2025.120447_b0060","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1177\/1352458520972573","article-title":"Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring","volume":"27","author":"Calabresi","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.cca.2025.120447_b0065","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2019.2137","article-title":"Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years","volume":"76","author":"Cant\u00f3","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/15368590252917647","article-title":"Monoclonal antibodies selective for low molecular weight neurofilaments","volume":"21","author":"Norgren","year":"2002","journal-title":"Hybrid. Hybridomics"},{"key":"10.1016\/j.cca.2025.120447_b0075","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1515\/cclm-2022-1181","article-title":"Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood","volume":"61","author":"Andreasson","year":"2023","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.cca.2025.120447_b0080","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/acn3.51355","article-title":"Comparison of SimoaTM and EllaTM to assess serum neurofilament\u2010light chain in multiple sclerosis","volume":"8","author":"Gauthier","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104177","article-title":"Serum neurofilament levels in patients with multiple sclerosis: a comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels","volume":"67","author":"Revendova","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.cca.2025.120447_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.935382","article-title":"Development of a highly sensitive neurofilament light chain assay on an automated immunoassay platform","volume":"13","author":"Lee","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","article-title":"Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis","volume":"80","author":"Meier","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.894119","article-title":"A method to combine neurofilament light measurements from blood serum and plasma in clinical and population-based studies","volume":"13","author":"R\u00fcbsamen","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0105","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2025.120447_b0110","article-title":"Neurofilament light levels are associated with long-term outcomes in multiple sclerosis","author":"Kuhle","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.cca.2025.120447_b0115","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1212\/NXI.0000000000000856","article-title":"Long-term prognostic value of longitudinal measurements of blood neurofilament levels","volume":"7","author":"H\u00e4ring","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.cca.2025.120447_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.819010","article-title":"Renal function and body mass index contribute to serum neurofilament light chain levels in elderly patients with atrial fibrillation","volume":"16","author":"Polymeris","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cca.2025.120447_b0125","first-page":"224","article-title":"Confounding effect of blood volume and body mass index on blood neurofilament light chain levels","volume":"51","author":"Manouchehrinia","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0130","first-page":"1","article-title":"Renal function is associated with blood neurofilament light chain level in older adults","author":"Akamine","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120447_b0135","doi-asserted-by":"crossref","DOI":"10.21037\/jlpm-24-33","article-title":"Determination of pediatric and adult reference intervals for neurofilament light chain (NfL) in blood and a comparison to other recent studies","author":"Figdore","year":"2024","journal-title":"J. Lab. Precis. Med."},{"key":"10.1016\/j.cca.2025.120447_b0140","doi-asserted-by":"crossref","DOI":"10.1177\/13524585241237388","article-title":"Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: a 48-week prospective single-center study","author":"Johnsson","year":"2024","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.cca.2025.120447_b0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/acn3.51704","article-title":"Associations of sNfL with clinico\u2010radiological measures in a large MS population","volume":"10","author":"Sotirchos","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106166","article-title":"Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis","volume":"92","author":"S\u00f8ndergaard","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.cca.2025.120447_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1354431","article-title":"Predictive value of individual serum neurofilament light chain levels in short-term disease activity in relapsing multiple sclerosis","volume":"15","author":"Sol\u00eds-Tarazona","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2025.120447_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119817","article-title":"Head-to-head comparison of four plasma neurofilament light chain (NfL) immunoassays","volume":"561","author":"Ashrafzadeh-Kian","year":"2024","journal-title":"Clin. Chim. Acta"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125003262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125003262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T21:44:48Z","timestamp":1753134288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125003262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":32,"alternative-id":["S0009898125003262"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120447","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120447"}}